Adalimumab appears safe in children with autoimmune disease: study

Adalimumab appears to be safe for treating paediatric patients with polyarticular juvenile idiopathic arthritis (JIA), enthesitis-related arthritis, psoriasis and Crohn's disease, according to data from company-sponsored clinical trials.